Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
RR Razonable - Frontiers in immunology, 2024 - frontiersin.org
While the general population regained a certain level of normalcy with the end of the global
health emergency, the risk of contracting COVID-19 with a severe outcome is still a major …
health emergency, the risk of contracting COVID-19 with a severe outcome is still a major …
[HTML][HTML] Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the …
J Railton, M Volonté, E Isoletta, A Bonelli… - Frontiers in …, 2024 - frontiersin.org
Objective The aim of this study is to review the life of patients with psoriasis on biologic
therapy during the SARS-CoV-2 pandemic and the relevance of frailty within this context …
therapy during the SARS-CoV-2 pandemic and the relevance of frailty within this context …
[HTML][HTML] Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated …
A Ketkar, V Willey, L Glasser, C Dobie, C Wenziger… - Advances in …, 2024 - Springer
Abstract Introduction/Methods EPOCH-US is an ongoing, retrospective, observational cohort
study among individuals identified in the Healthcare Integrated Research Database …
study among individuals identified in the Healthcare Integrated Research Database …
[HTML][HTML] The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in …
Y Hong, T Che, X Shen, J Chen, K Wang, L Zhao… - Frontiers in …, 2024 - frontiersin.org
Background The protective efficacy of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) vaccination against the new-onset gastrointestinal (GI) symptoms following …
(SARS-CoV-2) vaccination against the new-onset gastrointestinal (GI) symptoms following …
SARS-CoV-2 variants Omicron BA. 4/5 and XBB. 1.5 significantly escape T cell recognition in solid-organ transplant recipients vaccinated against the ancestral strain
T Halvorson, S Ivison, Q Huang, G Ladua… - …, 2024 - journals.lww.com
Background. Immune-suppressed solid-organ transplant recipients (SOTRs) display
impaired humoral responses to COVID-19 vaccination, but T cell responses are …
impaired humoral responses to COVID-19 vaccination, but T cell responses are …
[HTML][HTML] Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
M Torres-Rufas, EF Vicente-Rabaneda, L Cardeñoso… - Vaccines, 2024 - mdpi.com
Novel mechanisms of COVID-19 vaccines raised concern about their potential
immunogenicity in patients with rheumatoid arthritis (RA) undergoing immunomodulatory …
immunogenicity in patients with rheumatoid arthritis (RA) undergoing immunomodulatory …
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory …
DME Bowdish, V Chandran, CA Hitchon… - The Journal of …, 2024 - jrheum.org
Objective To determine how serologic responses to coronavirus disease 2019 (COVID-19)
vaccination and infection in immune-mediated inflammatory disease (IMID) are affected by …
vaccination and infection in immune-mediated inflammatory disease (IMID) are affected by …
Limited antibody response after BA. 4/5 adapted booster vaccination in rheumatic patients receiving anti-TNF therapy: results of a case series
UM Geisen, M Voß, R Rose, F Neumann… - Authorea …, 2023 - advance.sagepub.com
Limited antibody response after BA. 4/5 adapted booster vaccination in rheumatic patients
receiving anti-TNF therapy: results of a case seriesUlf Martin Geisen1*, Mathias Voß2 …
receiving anti-TNF therapy: results of a case seriesUlf Martin Geisen1*, Mathias Voß2 …
T Cell Responses to Repeated SARS-CoV-2 Vaccination and Breakthrough Infections in Patients on TNF Inhibitor Treatment: A Prospective Cohort Study
AS Wolf, KH Bjørlykke, HS Ørbo, S Bhandari, G Solum… - papers.ssrn.com
Background: Understanding cellular responses to SARS-CoV-2 immunisations is important
for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) …
for informing vaccine recommendations in patients with inflammatory bowel disease (IBD) …